EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach

Andreas Wasilewicz, Benjamin Kirchweger iD, Denisa Bojkova, Marie Jose Abi Saad, Julia Langeder, Matthias Bütikofer, Sigrid Adelsberger iD, Ulrike Grienke iD, Jindrich Cinatl, Olivier Petermann, Leonardo Scapozza, Julien Orts iD und 3 weitere

Journal of Natural Products · 2023

DOI: 10.1021/acs.jnatprod.2c00843 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Products, 2023. Verfasst von Andreas Wasilewicz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Biological Products, COVID-19. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung, Austrian Science Fund, Swiss Cancer Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsCOVID-19Molecular Docking SimulationHumansAntiviral AgentsProtease InhibitorsPeptide HydrolasesSARS-CoV-2MorusViral Proteases

Substanzen

Viral ProteasesPeptide HydrolasesAntiviral AgentsBiological ProductsProtease Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
  • Vienna Doctoral School of Pharmaceutical, Nutritional and Sport Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
  • Institute of Medical Virology, University Hospital Frankfurt, Paul-Ehrlich-Straße 40, 60596 Frankfurt am Main, Germany.
  • Swiss Federal Institute of Technology, Laboratory of Physical Chemistry, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland.
  • Pharmaceutical Biochemistry Group, School of Pharmaceutical Sciences, University of Geneva, 1205 Geneva, Switzerland.
  • Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, 1205 Geneva, Switzerland.

ORCID-Profile: Benjamin Kirchweger, Sigrid Adelsberger, Ulrike Grienke, Julien Orts, Johannes Kirchmair, Judith M Rollinger

Förderung

  • Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung
  • Austrian Science Fund
  • Swiss Cancer Research Foundation

Zitieren

APA

Wasilewicz, A., Kirchweger, B., Bojkova, D., Abi Saad, M. J., Langeder, J., Bütikofer, M., Adelsberger, S., Grienke, U., Cinatl, J., Petermann, O., Scapozza, L., Orts, J., Kirchmair, J., Rabenau, H. F., & Rollinger, J. M. (2023). Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.2c00843

Vancouver

Wasilewicz A, Kirchweger B, Bojkova D, Abi Saad MJ, Langeder J, Bütikofer M, et al. Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach. Journal of Natural Products. 2023. doi:10.1021/acs.jnatprod.2c00843

BibTeX
@article{Wasilewicz2023,
  author = {Wasilewicz, Andreas and Kirchweger, Benjamin and Bojkova, Denisa and Abi Saad, Marie Jose and Langeder, Julia and Bütikofer, Matthias and Adelsberger, Sigrid and Grienke, Ulrike and Cinatl, Jindrich and Petermann, Olivier and Scapozza, Leonardo and Orts, Julien and Kirchmair, Johannes and Rabenau, Holger F and Rollinger, Judith M},
  title = {Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach},
  journal = {Journal of Natural Products},
  year = {2023},
  doi = {10.1021/acs.jnatprod.2c00843}
}
Kostenlos starten →